John LaRocca

Insider Reports History

Location
C/O Y Mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York, NY
Signature
/s/ John LaRocca
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John LaRocca:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. SVP, General Counsel & Secry Common Stock 0 $0 $8.52 Sep 16, 2025 Direct
AERIE PHARMACEUTICALS INC General Counsel Common Stock 0 $15.25 Nov 21, 2022 Direct
AERIE PHARMACEUTICALS INC General Counsel Stock Option (right to buy) 0 $9.14 Nov 21, 2022 Direct
Y-mAbs Therapeutics, Inc. SVP, General Counsel & Secry Employee Stock Option (right to buy) 0 Sep 16, 2025 Direct

Insider Reports Filed by John LaRocca

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Sep 16, 2025 3 $0 4 Sep 18, 2025 SVP, General Counsel & Secry
YMAB Y-mAbs Therapeutics, Inc. Jan 17, 2025 2 $0 4 Jan 22, 2025 SVP, General Counsel & Secry
YMAB Y-mAbs Therapeutics, Inc. Jan 6, 2025 0 $0 3 Jan 16, 2025 SVP, General Counsel & Secry
AERI AERIE PHARMACEUTICALS INC Nov 21, 2022 2 -$1.24M 4 Nov 21, 2022 General Counsel
AERI AERIE PHARMACEUTICALS INC Aug 14, 2022 1 -$8.92K 4 Aug 16, 2022 General Counsel
AERI AERIE PHARMACEUTICALS INC Mar 18, 2022 2 $0 4 Mar 22, 2022 General Counsel
AERI AERIE PHARMACEUTICALS INC Feb 19, 2022 1 -$11.8K 4 Feb 23, 2022 General Counsel
AERI AERIE PHARMACEUTICALS INC Feb 7, 2022 1 -$5.56K 4 Feb 9, 2022 General Counsel
AERI AERIE PHARMACEUTICALS INC Feb 4, 2022 2 -$11.2K 4 Feb 8, 2022 General Counsel
AERI AERIE PHARMACEUTICALS INC Aug 14, 2021 1 -$11.2K 4 Aug 17, 2021 General Counsel